Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods (Q34926682)

5 August 2017

1 reference

title

Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods (English)

1 reference

5 August 2017

1 reference

1 reference

1 reference

Stripecke R

1

1 reference

5 August 2017

Levine AM

series ordinal

2

1 reference

5 August 2017

Pullarkat V

series ordinal

3

1 reference

5 August 2017

Cardoso AA

series ordinal

4

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

1974-1983

1 reference

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Treatment of acute myeloid leukaemia patients with recombinant interleukin 2: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Regulation of the immune response by antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Capture and processing of exogenous antigens for presentation on MHC molecules.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Modulating the immune response with dendritic cells and their growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Origin and differentiation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Successful T cell priming in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

B-cell development: a comparison between mouse and man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Prospect for immunotherapy of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Ex vivo priming for long-term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

CD80 (B7-1) expression on human acute myeloid leukaemic cells cultured with GM-CSF, IL-3 and IL-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Protective and therapeutic immunity against leukemia induced by irradiated B7-1 (CD80)-transduced leukemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Enhanced immune costimulatory activity of primary acute myeloid leukaemia blasts after retrovirus-mediated gene transfer of B7.1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Gene transfer to primary acute myeloid leukaemia blasts and myeloid leukaemia cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): delivery to acute myeloid leukemic blasts using adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

The role of the CD40 antigen on malignant B cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Transduction of acute myeloid leukemia cells with third generation self-inactivating lentiviral vectors expressing CD80 and GM-CSF: effects on proliferation, differentiation, and stimulation of allogeneic and autologous anti-leukemia immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Mylotarg: antibody-targeted chemotherapy comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

A third-generation lentivirus vector with a conditional packaging system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402701

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402701

1 reference

Dimensions Publication ID

5 August 2017

1037663222

0 references

1 reference